Scott Garber

Managing Partner

2019

Seed-stage B2B enterprise software investment focus https://earlylight.vc/

Investor

2013

https://garbervc.com/ Personal angel investments - 50 (mostly) early-stage enterprise software companies: Direct Portfolio Companies: Trusted Metrics, MissionMark, Majorclarity, Roundtrip Health, Pype, Osmosis Health, X-Mode, Insightin Health, rMark Bio, Feedtrail, Genamint/Conversive, Smalltalk, Syncurity, Lanehub, Appsulate, Ethix360, Cyr3con, Nayya Health, Turquoise Health, and Ash & Erie Syndicate Investments: UpEquity, Poppy, Faubion, ProductWind, Vita Therapeutics, Canvas GFX, Hunt a Killer, Bark Social, Larq, Carbon38, Yumi, ATAI, DailyPay, Epic Games, MasonHub, nate, Icon Build, Lumanu, Haus, Fast Twitch, Airlift, ClosedLoop AI, Sonic Incytes, Whisper Aero, Mulberry Technologies, Violet AI, Ottometric, Sepion Technologies, Turion Space, and ApponBoard

Adviser/Investor

2017 - 2021

Acquired by Elsevier in November 2021: https://www.bizjournals.com/baltimore/inno/stories/news/2021/12/03/baltimore-based-osmosis-acquired-by-amsterdam-firm.html Osmosis is a social & personalized learning platform for medical and health professions students. The proprietary Osmosis platform helps students succeed in their degree programs, on their high-stakes board exams, and ultimately in the clinic. Osmosis syncs directly with a medical school school’s curriculum and offers curated and custom developed content.

Operations Director

2018 - 2020

Board Observer and Investor

2014 - 2018

Acquired by SolarWinds, a $4.5 Billion cyber-security firm in July 2018

Entrepreneur In Residence

2017 - 2018

Deputy Head of Corporate Strategy & M&A

2015 - 2017

Deputy Head of Corporate Strategy & M&A for a multi-billion revenue company • Sized, analyzed, and prioritized nearly 20 Federal, commercial, state/local, and Canadian markets • Sourced, evaluated, and conducted due diligence on BTP Systems acquisition - evaluated all other investment opportunities & managed company-wide innovation portfolio initiatives • Bolstered net profit by 5%+ in 2016 by performing business case analysis on non-clinical healthcare and intelligent transportation systems businesses (exiting both businesses) • Built business development pipeline with business unit leaders by identifying opportunities, creating go-to-market strategies, and conducting competitive intelligence for $1+ billion in total contract value bids

Principal

2011 - 2014

Single family investment offices with linked managers & different investors • Participated in dozens of SEED, Series A, & Series B venture deals in six countries and seven states • Sourced & screened (due diligence, sensitivity analysis, financial modeling) hundreds of venture deals • Served as growth & business development lead in multiple startups to exceed sales goals through business development scoping and innovation programs (people, promotions, & partnerships)

Program Manager & Alternate Site Lead

2008 - 2011

2008-2009 and 2010-2011 • Designed & directed two business intelligence programs that optimized the client’s R&D operations • Directed engineering team engagement at client site on 17,000+ user IT development projects • Managed hundreds of client and stakeholder relationships and served as Chenega’s site leader

Senior Policy & Strategic Advisor

2009 - 2010

• 1 of 2 people to respond to near real-time inquiries from Congress & President Obama • Earned two individual awards from Agency Director for inventing, directing, & operating programs • Created Directorate-wide strategic plans & earned a Meritorious Unit Citation in 2009 with colleagues